Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 64, 2009 - Issue 6
60
Views
1
CrossRef citations to date
0
Altmetric
Case Report

ANGIOEDEMA BEYOND HISTAMINE: AN EDUCATIONAL CASE SERIES

, , , &
Pages 520-528 | Published online: 09 Jan 2014

REFERENCES

  • Lin RY, Shah SN. Increasing hospitalizations due to angioede-ma in the United States. Ann Allergy Asthma Immunol 2008; 101:185–92.
  • Temino VM, Peebles RS, Jr. The spectrum and treatment of an-gioedema. Am J Med 2008; 121:282–6.
  • Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007; 62:842–56.
  • Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693–7.
  • Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int lmmunopharmacol 2003; 3:311–7.
  • Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006; 26:725–37.
  • Malde B, Regalado J, Greenberger PA. Investigation of angioe-dema associated with the use of angiotensin-converting en-zyme inhibitors and angiotensin receptor Mockers. Ann Allergy Asthma Immunol 2007; 98:57–63.
  • Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA, Jr. Multicenter study of patients with angiotensin-convert-ing enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008; 100:327–32.
  • Campbell DJ, Krum H, Ester MD. Losartan increases bradykinin levels in hypertensive humans. Circulation 2005; 111:315–20.
  • Hellebrand MC, Kojda G, Hoffmann TK, Bas M. (Angioedema due to ACE inhibitors and AT(1) receptor antagonists). Hautarzt 2006; 57:808–10.
  • Haymore BR, Yoon J, Mikita CP, Mote MM, DeZee KJ. Risk of an-gioedema with angiotensin receptor Mockers in patients with prior angioedema associated with angiotensin-converting en-zyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 2008; 101:495–9.
  • Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am] Hypertens 2004; 17:103–11.
  • Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrin-olysis, and kinin generation. J Clin Invest 1973; 52:1402–9.
  • Davis AE, III. Cl inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 6:595-628.:595–628.
  • Nielsen EW, Johansen HT, Hogasen K, Wuillemin W, Hack CE, Manes TE. Activation of the complement, coagulation, fibrin-olytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand J Immunol 1996; 44:185–92.
  • Cugno M, Cicardi M, Bottasso B et al. Activation of the coagula-tion cascade in C1-inhibitor deficiencies. Blood 1997; 89:3213–8.
  • Davis AE, Ill. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am 2006; 26:633–51.
  • Varga L, Szeplaki G, Laki J et al. Depressed activation of the lectin pathway of complement in hereditary angioedema. Clin Exp Immunol 2008; 153:68–74.
  • Cicardi M, Zingale LC. The deficiency of Cl inhibitor and its treatment. lmmunobiology 2007; 212:325–31.
  • Joseph K, Tuscano TB, Kaplan AP. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol 2008; 101:279–86.
  • Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioede-ma with normal C1-inhibitor activity in women. Lancet 2000; 356:213–7.
  • Binkley KE, Davis A, Ill. Clinical, biochemical, and genetic char-acterization of a novel estrogen-dependent inherited form of a ngioedema. J Allergy Clin Immunol 2000; 106:546–50.
  • Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal Cl inhibitor. Biochem Biophys Res Commun 2006; 343:1286–9.
  • Cichon S, Martin L, Hennies HC et al. Nothen MM. Increased activity of coagulation factor XII (Hageman factor) causes he-reditary angioedema type III. Am J Hum Genet 2006; 79:1098–104.
  • Farsetti A, Misiti S, Citarella F et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinol-ogy 1995; 136:5076–83.
  • Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am] Med 1999; 106:650–4.
  • Gupta S, Yu F, Klaustermeyer WB. New-variant hereditary an-gioedema in three brothers with normal Cl esterase inhibitor level and function. Allergy 2004; 59:557–8.
  • Bork K, Gul D, Dewald G. Hereditary angio-oedema with nor-mal Cl inhibitor in a family with affected women and men. Br J Dermatol 2006; 154:542–5.
  • Gompels MM, Lock RJ, Abinun M et al. Cl inhibitor deficiency: consensus document. Clin Exp Immunol 2005; 139:379–94.
  • Bowen T, Cicardi M, Bork K et al. Hereditary angiodema: a cur-rent state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asth-ma Immunol 2008; 100:S30–S40.
  • Agostoni A, ygoren-Pursun E, Binkley KE et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third Cl esterase inhibitor deficiency workshop and be-yond./ Allergy Clin Immunol 2004; 114:551–131.
  • Zingale LC, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006; 175:1065–70.
  • Ebo DG, Stevens WJ. Hereditary angioneurotic edema: review of the literature. Acta Clin Belg 2000; 55:22–9.
  • Farkas H, Varga L, Szeplaki G, Visy B, Harmat G, Bowen T. Man-agement of hereditary angioedema in pediatric patients. Pedi-atrics 2007; 120:e713–e722.
  • Zuraw BL, Christiansen SC. New promise and hope for treat-ing hereditary angioedema. Expert Opin lnvestig Drugs 2008; 17:697–706.
  • Grattan CE. Autoimmune urticaria. Immunol Allergy Clin North Am 2004; 24:163–81, v.
  • Ozdemir O. Idiopathic (autoimmune) chronic urticaria. Allergy Asthma Proc 2006; 27:431–4.
  • Boguniewicz M. The autoimmune nature of chronic urticaria. AllergyAsthma Proc 2008; 29:433–8.
  • Ebo DG, Sainte-Laudy J, Bridts CH et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006; 61:1028–39.
  • Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ. Basophil activation test by flow cytometry: pres-ent and future applications in allergology. Cytometry B Clin Cy-tom 2008; 74:201–10.
  • Gyimesi E, Sipka S, Danko K et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151:388–96.
  • De SwerdtA., Van Den KC, Kasran A et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin lmmunol 2005; 116:662–7.
  • Frezzolini A, Provini A, Teofoli P, Pomponi D, De PO. Serum-in-duced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urti-caria. Allergy 2006; 61:1071–7.
  • Altrich M, Halsey J, Altman L. Comparison of the in vivo au-tologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria. Allergy Asthma Proc 2008.
  • Weiler CR, van Dellen RG. Genetic test indications and inter-pretations in patients with hereditary angioedema. Mayo Clin Proc 2006; 81:958–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.